ADC Review | Journal of Antibody-drug Conjugates

@adc_review_journal_of_antibody_drug_conjugates

Chandler, Arizona

http://www.adcreview.com

Biotechnology Research

Overview

About ADC Review | Journal of Antibody-drug Conjugates

ADC Review | Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an online hybrid, open access, international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policy makers.

Join over 21,000 readers worldwide, subscribe today.

Headquarters

Chandler, Arizona

Website

http://www.adcreview.com

Company Size

2-10 employees

Industry

Biotechnology Research

Company Type

Founded

2013

Specialties

ADC, Antibody-drug Conjugates, Targeted Therapies, Anti-Cancer Drugs, Drug Development, Antibody, Peer Reviewed Journal, Oncology, Hematology, antibody drug conjugates, ADC Review, Monoclonal Antibody, Linker Chemistry, Biopharma, Biotechnology, and Pharmaceuticals